RecruitingNot ApplicableNCT06820593

Technology-Enhanced Asthma Care in Children at Clinic and Home Study

Technology-Enhanced Asthma Care in Children at Clinic and Home (TEACCCH) Study (Aim 2): A Feasibility Randomized Controlled Trial

Sponsor

Ann & Robert H Lurie Children's Hospital of Chicago

Enrollment

80 participants

Start Date

Mar 14, 2025

Study Type

INTERVENTIONAL

Conditions

Asthma in Children Chronic Diseases in Children

Summary

A randomized controlled trial with parent-child pairs of children with persistent or uncontrolled asthma. An intervention group (n=40 parent-child pairs) will receive the mobile health (mHealth) app and digital sensors with enhanced support from a population health manager role, hereinafter referred to as an asthma coordinator, to provide remote patient monitoring (RPM). A comparison group (n=40 parent-child pairs) will receive the mHealth app and sensors without RPM support to silently collect inhaler use information without mHealth app features. The focus of this project is to evaluate the feasibility and acceptability of delivering a digital intervention for pediatric asthma with RPM in the outpatient setting.

Eligibility

Min Age: 4 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether technology-enhanced asthma care — including digital tools used both at the clinic and at home — can improve asthma management in children compared to standard care. Parent-child pairs participate together. **You may be eligible if...** - You are a parent or legal guardian aged 18 or older with a child aged 4 to 17 who has been diagnosed with asthma - The child's asthma diagnosis is documented in their medical record - You and your child are willing to use digital health tools **You may NOT be eligible if...** - The child has a medical or behavioral condition that, in the study team's opinion, would make participation unsafe - The child is younger than 4 or older than 17 years Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDigital Asthma Intervention

The intervention consists of two main components-the mHealth app and sensors that is part of the Adherium's Hailie® Solution-and the remote patient monitoring (RPM), conducted in this intervention by an asthma coordinator.

BEHAVIORALComparison Group

Participants in the comparison group will receive the sensors for their ICS inhalers and a limited version of the app that only collects the sensor information by Bluetooth, without app features, and sends the information to the Hailie web portal. This passive adherence data collection will allow for comparison of the two groups' adherence rates without the mHealth app self-management support or RPM.